Vegzelma
These highlights do not include all the information needed to use VEGZELMA safely and effectively. See full prescribing information for VEGZELMA. VEGZELMA (bevacizumab-adcd) injection, for intravenous use Initial U.S. Approval: 2022 VEGZELMA (bevacizumab-adcd) is biosimilar to AVASTIN (bevacizumab).
4cdcccda-7b9a-49d0-ac50-f4605a3c0ebe
HUMAN PRESCRIPTION DRUG LABEL
Feb 22, 2023
CELLTRION USA, Inc.
DUNS: 116587378
Products 2
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
bevacizumab-adcd
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (6)
bevacizumab-adcd
Product Details
FDA regulatory identification and product classification information